Consideration before administering cytotoxic chemotherapy to the critically ill

Critical Care Medicine

Volumn 33, Issue 11, 2005, Pages 2689-2691

  Tanvetyanon, Tawee ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Cancer; Chemotherapy; Intensive care unit

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOTOXIC AGENT; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; ERLOTINIB; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IDARUBICIN; OXALIPLATIN; PACLITAXEL; PREDNISONE; PROCARBAZINE; RITUXIMAB; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADVANCED CANCER; ARTIFICIAL VENTILATION; BREAST CANCER; CANCER; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; COLORECTAL CANCER; CRITICAL ILLNESS; DISEASE EXACERBATION; DRUG SAFETY; DRUG USE; EDITORIAL; FATIGUE; GERM CELL TUMOR; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; INTENSIVE CARE UNIT; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MUCOSA INFLAMMATION; NAUSEA; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; STOMACH CANCER; THROMBOSIS; TUMOR LYSIS SYNDROME; VOMITING;

EID: 27944433790     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000186772.12348.40     Document Type: Editorial

References (20)

1. Jennens RR, Rosenthal MA, Mitchell P, et al: Outcome of patients admitted to the intensive care unit with newly diagnosed small cell lung cancer. Lung Cancer 2002; 38:291-296
2. Kirch C, Blot F, Fizazi K, et al: Acute respiratory distress syndrome after chemotherapy for lung metastases from non-seminomatous germ-cell tumors. Support Care Cancer 2003; 11:575-580
3. Darmon M, Thiery G, Ciroldi M, et al: Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med 2005; 33:2488-2493
4. Nelson JE, Meier DE, Oei EJ, et al: Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med 2001; 29:277-282
5. Schapira DV, Studnicki J, Bradham DD, et al: Intensive care, survival, and expense of treating critically ill cancer patients. JAMA 1993; 10269:783-786
6. Schiller JH, Harrington D, Belani CP, et al: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002; 346:92-98
7. de Gramont A, Figer A, Seymour M, et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18:2938-2947
8. Schmid P, Schippinger W, Nitsch T, et al: Up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: Results of a randomized trial. J Clin Oncol 2005; 23:432-440
9. Thuss-Patience PC, Kretzschmar A, Repp M, et al: Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: A randomized phase II study. J Clin Oncol 2005; 23:494-501
10. Moore MJ, Goldstein D, Hamm J, et al: Erlotinib plus gemcitabine compared to gemcitabine alone in patients with advanced pancreatic cancer. Abstr 1. Proc ASCO 2005
11. Bolis G, Scarfone G, Polverino G, et al: Paclitaxel 175 or 225 mg per meters squared with carboplatin in advanced ovarian cancer: A randomized trial. J Clin Oncol 2004; 22:686-690
12. Coiffier B, Lepage E, Briere J, et al: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346:235-242
13. Moore JO, George SL, Dodge RK, et al: Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222. Blood 2005; 105:3420-3427
14. Thomas X, Boiron JM, Huguet F, et al: Outcome of treatment in adults with acute lymphoblastic leukemia: Analysis of the LALA-94 trial. J Clin Oncol 2004; 22:4075-4086
15. Diehl V, Franklin J, Pfreundschuh M, et al: Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N Engl J Med 2003; 348:2386-2395
16. Tanvetyanon T, Choudhury AM: Fatal acute tumor lysis syndrome, hepatic encephalopathy and flare phenomenon following combined androgen blockade. J Urol 2004; 171:1627
17. Sharma RA, Decatris MP, Santhanam S, et al: Reversibility of liver failure secondary to metastatic breast cancer by vinorelbine and cisplatin chemotherapy. Cancer Chemother Pharmacol 2003; 52:367-370
18. Hilbert G, Gruson D, Vargas, et al: Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344:481-487
19. Levine MN, Gent M, Hirsh J, et al: The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. N Engl J Med 1988; 318:404-407
20. Hirsch DR, Ingenito EP, Goldhaber SZ: Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 1995; 274:335-337